JSW Clinical Investigations

JSW Clinical Investigations was a contract research organization (CRO) alliance specializing in Phase II-IV clinical drug development services. Formed as a joint alliance between JSW Life Sciences and two other CROs, the entity focused on providing comprehensive clinical trial services to pharmaceutical and biotechnology companies worldwide. Its primary expertise lay in central nervous system (CNS) diseases, including Alzheimer's, Parkinson's, and schizophrenia, leveraging the deep scientific background of its founder, Dr. Manfred Windisch. Following the acquisition of JSW Life Sciences by QPS in 2012, the clinical operations were largely integrated into the QPS global network, and the specific UK-registered entity was dissolved in 2014.